Stock MAIA MAIA BIOTECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases MAIA Biotechnology, Inc.

Equities

MAIA

US5526411021

Market Closed - Nyse
Other stock markets
 21:00:00 12/06/2024 BST 		5-day change 1st Jan Change
3.72 USD -5.10% Intraday chart for MAIA Biotechnology, Inc. +15.17% +217.95%
06-07 MAIA Biotechnology Shares Rise After FDA's Telomerase Inhibitor Approval Shows Viability of Such Therapies DJ
06-07 MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA?s Approval of a Telomerase Inhibitor Agent Therapy CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy
BU
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
BU
Groundbreaking Study by MAIA Biotechnology (NYSE: MAIA) Indicates Promising New Treatment for Advanced Lung Cancer
AQ
MAIA BIOTECHNOLOGY REVEALS NEW CLINICAL DATA SHOWING THIO'S STRONG EFFICACY IN NON-SMALL CELL LUNG CANCER
AQ
MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer
BU
MAIA Biotechnology : Poster (June 2024)
PU
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation
AQ
MAIA BIOTECHNOLOGY TO PRESENT AT THE BIO INTERNATIONAL CONVENTION 2024
AQ
MAIA BIOTECHNOLOGY ABSTRACT ACCEPTED FOR POSTER PRESENTATION AT AMERICAN SOCIETY OF CLINICAL ONCOLOGY 2024 ANNUAL MEETING
AQ
MAIA Biotechnology to Present at the BIO International Convention 2024
BU
MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
BU
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement
BU
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement
BU
MAIA Biotechnology Announces $1.00 Million Private Placement
BU
MAIA BIOTECHNOLOGY TO PRESENT AT TWO INVESTOR CONFERENCES IN APRIL 2024
AQ
MAIA Biotechnology to Present at Two Investor Conferences in April 2024
BU
MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero
BU
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement
BU
MAIA Biotechnology Announces $1.33 Million Private Placement
BU
MAIA BIOTECHNOLOGY ANNOUNCES SHARE PURCHASE BY DIRECTOR STAN SMITH, PHD IN A $2.9 MILLION PRIVATE PLACEMENT
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MAIA Stock
  4. News MAIA Biotechnology, Inc.
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW